Jamieson is delighted to announce that it has advised the founder and the management team of Pharmalex on the sale of the business to AmerisourceBergen.
PharmaLex is a global team of scientific, regulatory, and safety and compliance (GxP) experts that provide strategic guidance and regulatory support to biopharma companies throughout a product’s lifecycle. Under the current management team, the company has become the leading provider of specialized services for the life science industry. Pharmalex provides tech-enabled services ranging from marketing authorization to clinical development consulting, enabling clients to effectively bring products to global markets and diverse patient populations.
Felix Rose, Sabrina Goetz, and Christian Koenner advised the founder Mr. Dobmeyer (CEO) and the further Management team on the transaction.
